Millennium Management’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Millennium Management’s Portfolio ANTH Stock Details ANTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-67,339	Closed	-$111K	–	4336
2017 Q4	$111K	Sell	67,339 -52,792	-44%	-$90.8K	﹤0.01%	3645
2017 Q3	$173K	Sell	120,131 -36,608	-23%	-$52K	﹤0.01%	3280
2017 Q2	$254K	Buy	156,739 +144,157	+1,146%	+$323K	﹤0.01%	3099
2017 Q1	$43K	Sell	12,582 -34,949	-74%	-$165K	﹤0.01%	3398
2016 Q4	$247K	Buy	47,531 +45,168	+1,911%	+$782K	﹤0.01%	2998
2016 Q3	$60K	Sell	2,363 -5,708	-71%	-$144K	﹤0.01%	3179
2016 Q2	$200K	Buy	+8,071	New	+$228K	﹤0.01%	2905
2016 Q1	–	Sell	-43,338	Closed	-$1.61M	–	3876
2015 Q4	$1.61M	Sell	43,338 -3,619	-8%	-$160K	﹤0.01%	2066
2015 Q3	$2.29M	Buy	46,957 +40,563	+634%	+$2.83M	﹤0.01%	1814
2015 Q2	$441K	Buy	6,394 +3,369	+111%	+$156K	﹤0.01%	2694
2015 Q1	$108K	Buy	+3,025	New	+$89.5K	﹤0.01%	3394

Other funds holding ANTH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Millennium Management's ANTH Position: Q1 2018 in Review

Millennium Management sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q1 2018, closing a stake of 67,339 shares — an estimated $111K sold.

Millennium Management first reported a position in ANTH in Q1 2015 and held it in 11 quarters. The position peaked at $2.29M in Q3 2015. 28 funds tracked by Wall St. Rank hold ANTH as of Q1 2018.

Millennium Management reported no remaining Anthera Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
Millennium Management sold 67,339 Anthera Pharmaceuticals, Inc. shares in Q1 2018, an estimated $111K.
Millennium Management first reported a position in Anthera Pharmaceuticals, Inc. in Q1 2015 and held it in 11 quarters.
Millennium Management's Anthera Pharmaceuticals, Inc. position peaked at $2.29M in Q3 2015.
28 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q1 2018.

Based on Millennium Management's 13F filing for Q1 2018, filed 15 May 2018.